You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria
  1. Lorenzo Cavagna1,
  2. Santos Castañeda2,3,
  3. Carlo Sciré4,
  4. Miguel A Gonzalez-Gay5
  5. On Behalf of the AENEAS Collaborative Group Members
  1. 1 Department of Rheumatology, University and IRCCS Foundation Policlinico S. Matteo, Pavia, Italy
  2. 2 Department of Rheumatology, Hospital Universitario La Princesa, Madrid, Spain
  3. 3 Department of Rheumatology, FJD, Madrid, Spain
  4. 4 Dipartimento di Scienze Mediche, Universita degli Studi di Ferrara, Ferrara, Emilia-Romagna, Italy
  5. 5 Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
  1. Correspondence to Dr Lorenzo Cavagna, Departement of Rheumatology, University and IRCCS Foundation Policlinico S. Matteo, Pavia 27100, Italy; lorenzo.cavagna{at}unipv.it

https://doi.org/10.1136/annrheumdis-2017-212368

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the extended report by Lilleker et al 1 on the EuroMyositis registry. Our attention was particularly addressed to antisynthetase syndrome (ASSD) because in the last years we and all members of the AENEAS (American and European Network of Antisynthetase Syndrome) collaborative group strongly contributed2–7 to increase the knowledge on this peculiar disease.

    We think that a comparison between our cohorts could be of interest and useful for clinicians, even if the lack of some data in the EuroMyositis paper does not allow us to perform statistical analysis. Both groups collected a very large number of patients (AENEAS collaborative group 813 cases, EuroMyositis 512 cases). The comparison of available …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Patient consent Obtained.

    • Ethics approval Obtained.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • Correspondence response
      Response to: ‘Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria’ by Cavagna et al
      James B Lilleker Jiri Vencovsky Guochun Wang Lucy R Wedderburn Louise P Diederichsen Jens Schmidt Paula Jordan Olivier Benveniste Maria Giovanna Danieli Katalin Dankó Nguyen Thi Phuong Thuy Monica Vázquez-Del Mercado Helena Andersson Boel De Paepe Jan L De Bleecker Britta Maurer Liza J McCann Nicolo Pipitone Neil McHugh Zoe Betteridge Paul New Robert G Cooper William E Ollier Janine A Lamb Niels Steen Krogh Ingrid E Lundberg Hector Chinoy
      Annals of the Rheumatic Diseases 2017; 77 e51-e51 Published Online First: 19 Dec 2017. doi: 10.1136/annrheumdis-2017-212382